What is NeuroScouting?
NeuroScouting is at the forefront of developing sophisticated applications and training technologies that harness the power of neuroscience to enhance athletic performance and promote brain health. Established by neuroscientists Dr. Wesley Clapp and Dr. Brian Miller, the company expertly combines software and hardware to engineer innovative diagnostic and training platforms. These solutions are designed for elite athletes and are also finding applications in healthcare. NeuroScouting's multidisciplinary team collaborates closely with professional sports organizations and healthcare providers, aiming to elevate player development and optimize brain-body system functions through cutting-edge research and technological integration.
How much funding has NeuroScouting raised?
NeuroScouting has raised a total of $380K across 2 funding rounds:
Debt
$150K
Debt
$230K
Debt (2020): $150K with participation from PPP
Debt (2021): $230K led by PPP
Key Investors in NeuroScouting
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for NeuroScouting?
With its recent major strategic investment, NeuroScouting is poised for accelerated growth and market expansion. The substantial capital infusion, indicated by the large-scale late-stage funding context, suggests a strategic focus on scaling operations, further research and development, and potentially broadening its market reach into new athletic disciplines or healthcare sectors. This backing will likely enable the company to enhance its existing diagnostic and training platforms and explore new frontiers in neuro-performance technology, solidifying its leadership in the intersection of neuroscience and sports science.
See full NeuroScouting company page
